Trials / Sponsors / Oncternal Therapeutics, Inc
Oncternal Therapeutics, Inc
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2023-09-20 |
| Terminated | A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies Relapsed/Refractory Aggressive B-Cell Malignancies | Phase 1 / Phase 2 | 2023-05-09 |
| Withdrawn | A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders | Phase 3 | 2023-03-01 |
| Completed | A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2018-01-03 |
| Terminated | TK216 in Patients With Relapsed or Refractory Ewing Sarcoma Sarcoma, Ewing | Phase 1 / Phase 2 | 2016-08-01 |